Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut
NCT03068650
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Recurrent GBM
Interventions
BIOLOGICAL:
rindopepimut
Sponsor
Celldex Therapeutics